Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brighton Pharmaceuticals
Toms River, New Jersey, United Statesbrightonpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Brighton Pharmaceuticals was a privately held specialty pharmaceutical company based in New Jersey that focused on the development and registration of generic prescription drugs. The company specialized in creating a pipeline of Abbreviated New Drug Applications (ANDAs) targeting therapeutic areas such as dermatology, women's health, and pain management. In 2008, Brighton Pharmaceuticals was acquired by Perrigo Company for approximately $20 million. This acquisition allowed Perrigo to significantly expand its generic Rx product portfolio and leverage Brighton's development expertise to strengthen its position in the US generic pharmaceutical market.
- Therapeutic areas
- NeurologyWomen's HealthDermatology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Brighton Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Brighton Pharmaceuticals.